1. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.
- Author
-
Zamparelli, Marco Sanduzzi, Compare, Debora, Coccoli, Pietro, Rocco, Alba, Nardone, Olga Maria, Marrone, Giuseppe, Gasbarrini, Antonio, Grieco, Antonio, Nardone, Gerardo, and Miele, Luca
- Subjects
- *
DISEASE prevalence , *TYPE 2 diabetes , *METABOLIC disorders , *CARDIOVASCULAR diseases risk factors , *HUMAN microbiota - Abstract
The prevalence of metabolic disorders, such as type 2 diabetes (T2D), obesity, and non-alcoholic fatty liver disease (NAFLD), which are common risk factors for cardiovascular disease (CVD), has dramatically increased worldwide over the last decades. Although dietary habit is the main etiologic factor, there is an imperfect correlation between dietary habits and the development of metabolic disease. Recently, research has focused on the role of the microbiome in the development of these disorders. Indeed, gut microbiota is implicated in many metabolic functions and an altered gut microbiota is reported in metabolic disorders. Here we provide evidence linking gut microbiota and metabolic diseases, focusing on the pathogenetic mechanisms underlying this association. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF